It is recommended that two (2) capsules of Lister-V be taken four (4) times daily for seven (7) days. Primary Ingredients
Lister-V is a proprietary formulation of amino acids and other dietary factors to support induction, maintenance, and enhancement of the specific neurotransmitter activity
involved in the physiology of IR. The formulation consists of nonessential and essential amino acids, L-Arginine HCL, L-Glutamine, L-Histidine HCL, L-Leucine, L-Cysteine,
Lecithin, Echinacea, Green Tea Extract, Cinnamon, Cocoa Extract, Whey Protein Isolate (Milk), Zinc, and Grape Seed Extract. These ingredients fall into the category of
“Generally Regarded as Safe” (GRAS) as defined by the Food and Drug Administration (FDA) (Sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act). A
GRAS substance is distinguished from a food additive on the basis of the common knowledge about the safety of the substance for its intended use. The standard for an
ingredient to achieve GRAS status requires not only technical demonstration of non-toxicity and safety, but also general recognition of safety through widespread usage
and agreement of that safety by experts in the field. Many ingredients have been determined by the U.S. Food and Drug Administration (FDA) to be GRAS, and are listed
as such by regulation, in Volume 21 Code of Federal Regulations (CFR) Sections 182, 184, and 186.
Amino Acids
Amino Acids are the building blocks of protein. All amino acids are GRAS listed as they have been ingested by humans for thousands of years. The doses of the amino
acids in Lister-V are equivalent to those found in the usual human diet; however the formulation uses specific ratios of the key ingredients to elicit a therapeutic response.
Patients with a viral disease may require an increased amount of certain amino acids that cannot be obtained from normal diet alone. Choline, for example, is an essential
amino acid. The body cannot make choline and must obtain choline from the diet. Choline is required to fully potentiate nitric oxide synthesis in the nasal passage and
lungs. A deficiency of choline leads to reduced nitric oxide production in the nasal passage and lungs. Flavonoids potentiate the production of nitric oxide in the nasal
passage and lungs. Choline deficient diets and diets deficient in flavonoid rich foods can result in inadequate flavonoid concentrations, impeding nitric oxide production.
Provision of arginine, choline, and flavonoids with antioxidants, in specific proportions can restore the production of beneficial nitric oxide, thereby inhibiting viral growth.
Other Ingredients
Lister-V contains the following inactive or other ingredients, as fillers, excipients, and colorings: Gelatin, vegetable magnesium stearate, silicon dioxide, lac-resin, and
carmine.
Physical
